NCT06865144View on ClinicalTrials.gov

Effect of Rhopressa on Intraocular Pressure (IOP) in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension Post-SLT

PHASE4RecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

June 27, 2025

Primary Completion Date

April 1, 2026

Study Completion Date

April 1, 2026

Conditions
Primary Open Angle Glaucoma or Ocular Hypertension
Interventions
DRUG

Netarsudil ophthalmic solution 0.02%

Apply one drop in each eye every evening

DRUG

Artificial tears

Apply one drop in each eye every evening

Trial Locations (1)

32256

RECRUITING

East Coast Institute for Research at Florida Eye Specialists, Jacksonville

Sponsors
All Listed Sponsors
collaborator

Alcon, a Novartis Company

INDUSTRY

collaborator

Florida Eye Specialists

UNKNOWN

lead

East Coast Institute for Research

NETWORK